ProShare Advisors’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $614K | Buy |
|
|||||
|
2023
Q3 | $286K | Buy |
|
|||||
|
2023
Q2 | $209K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $76K | Sell |
|
|||||
|
2021
Q4 | $92K | Buy |
|
|||||
|
2021
Q3 | $86K | Sell |
|
|||||
|
2021
Q2 | $132K | Buy |
|
|||||
|
2021
Q1 | $127K | Buy |
|
|||||
|
2020
Q4 | $149K | Buy |
|
|||||
|
2020
Q3 | $142K | Sell |
|
|||||
|
2020
Q2 | $71K | Buy |
|
|||||
|
2020
Q1 | $20K | Sell |
|
|||||
|
2019
Q4 | $47K | Sell |
|
|||||
|
2019
Q3 | $135K | Buy |
|
|||||
|
2019
Q2 | $189K | Sell |
|
|||||
|
2019
Q1 | $354K | Buy |
|
|||||
|
2018
Q4 | $207K | Buy |
|